JP2024540485A5 - - Google Patents

Info

Publication number
JP2024540485A5
JP2024540485A5 JP2024529343A JP2024529343A JP2024540485A5 JP 2024540485 A5 JP2024540485 A5 JP 2024540485A5 JP 2024529343 A JP2024529343 A JP 2024529343A JP 2024529343 A JP2024529343 A JP 2024529343A JP 2024540485 A5 JP2024540485 A5 JP 2024540485A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
compound
membered heterocycles
carbon rings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540485A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/050313 external-priority patent/WO2023091606A1/en
Publication of JP2024540485A publication Critical patent/JP2024540485A/ja
Publication of JP2024540485A5 publication Critical patent/JP2024540485A5/ja
Pending legal-status Critical Current

Links

JP2024529343A 2021-11-17 2022-11-17 ピリダジノン化合物およびその使用 Pending JP2024540485A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163280457P 2021-11-17 2021-11-17
US63/280,457 2021-11-17
PCT/US2022/050313 WO2023091606A1 (en) 2021-11-17 2022-11-17 Pyridazinone compounds and uses thereof

Publications (2)

Publication Number Publication Date
JP2024540485A JP2024540485A (ja) 2024-10-31
JP2024540485A5 true JP2024540485A5 (https=) 2025-11-25

Family

ID=84519449

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529343A Pending JP2024540485A (ja) 2021-11-17 2022-11-17 ピリダジノン化合物およびその使用

Country Status (4)

Country Link
US (1) US20240336609A1 (https=)
EP (1) EP4433473A1 (https=)
JP (1) JP2024540485A (https=)
WO (1) WO2023091606A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2958954T3 (es) 2018-11-06 2024-02-16 Edgewise Therapeutics Inc Compuestos de piridazinona y usos de los mismos
WO2020097258A1 (en) 2018-11-06 2020-05-14 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
EP3877052B1 (en) 2018-11-06 2023-08-16 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
EP4149620B1 (en) * 2020-05-13 2024-10-23 Edgewise Therapeutics, Inc. Pyridazinone compounds for the treatment of neuromuscular diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2293638T3 (es) 1994-03-25 2008-03-16 Isotechnika, Inc. Mejora de la eficacia de farmacos por deuteracion.
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
DE102007025718A1 (de) * 2007-06-01 2008-12-04 Merck Patent Gmbh Pyridazinonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
TWI829634B (zh) * 2017-04-06 2024-01-21 美商富曼西公司 殺真菌之噁二唑
ES2958954T3 (es) * 2018-11-06 2024-02-16 Edgewise Therapeutics Inc Compuestos de piridazinona y usos de los mismos
EP3877052B1 (en) * 2018-11-06 2023-08-16 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
EP4149620B1 (en) * 2020-05-13 2024-10-23 Edgewise Therapeutics, Inc. Pyridazinone compounds for the treatment of neuromuscular diseases

Similar Documents

Publication Publication Date Title
JP2024540485A5 (https=)
JP2023526248A5 (https=)
JP2022506686A5 (https=)
JP2023526247A5 (https=)
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
JP2022506685A5 (https=)
JP2016534134A5 (https=)
JP2021527126A5 (https=)
HRP20110252T1 (hr) Fenil-karboksamidni spojevi korisni za liječenje boli
JP2021534106A5 (https=)
EP3224237B1 (en) Necrosis inhibitors
CA2511509A1 (en) Benzoazolylpiperazine derivatives having vr1 antagonist activity
HRP20090442T1 (hr) Heteroaril-tetrahidropiridil spojevi korisni za liječenje ili prevenciju boli
JPH04503212A (ja) ５―リポキシゲナーゼ阻止剤としての４―ヒドロキシチアゾール
RU2016120610A (ru) Производное сульфонамида и его применение в медицине
CA2491079A1 (en) Therapeutic piperazine derivatives useful for treating pain
JP2005501855A5 (https=)
RU2008107733A (ru) Ингибиторы gsk-3
JPWO2023195529A5 (https=)
CA2534088A1 (en) 2,3-substituted pryidl compounds useful for treating pain
JP2023526050A5 (https=)
JP2021524487A5 (https=)
JP2022550221A5 (https=)
JP2025504963A5 (https=)
CA2626402A1 (en) Potassium channel inhibitors